Skip to main content

JonesTrading Remains a Buy on Achieve Life Sciences (ACHV)

Tipranks - Tipranks - Fri Aug 8, 2025

JonesTrading analyst Justin Walsh reiterated a Buy rating on Achieve Life Sciences today and set a price target of $20.00. The company’s shares closed today at $2.64.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

According to TipRanks, Walsh is an analyst with an average return of -2.3% and a 31.50% success rate. Walsh covers the Healthcare sector, focusing on stocks such as Perspective Therapeutics, Y-Mabs Therapeutics, and Bioline RX Ltd Sponsored ADR.

Achieve Life Sciences has an analyst consensus of Strong Buy, with a price target consensus of $15.25.

See today’s best-performing stocks on TipRanks >>

Based on Achieve Life Sciences’ latest earnings release for the quarter ending March 31, the company reported a quarterly GAAP net loss of $12.83 million. In comparison, last year the company had a GAAP net loss of $6.49 million

Read More on ACHV:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).